Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

2012512 citationsJournal Articlebronze Open Access

Authors

Vincenzo Mazzaferro · Fondazione IRCCS Istituto Nazionale dei Tumori

Carlo Sposito · Fondazione IRCCS Istituto Nazionale dei Tumori

Sherrie Bhoori · Fondazione IRCCS Istituto Nazionale dei Tumori

Raffaele Romito · Fondazione IRCCS Istituto Nazionale dei Tumori

Claudio Chiesa · Fondazione IRCCS Istituto Nazionale dei Tumori

Carlo Morosi · Fondazione IRCCS Istituto Nazionale dei Tumori

Abstract

Y90RE is an effective treatment in intermediate to advanced HCC, particularly in the case of PVT. Further prospective evaluations comparing Y90RE with conventional treatments are warranted.

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Liver Disease Diagnosis and Treatment Hepatitis B Virus Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hepatology

Volume 57, Issue 5, pp. 1826-1837

DOI: 10.1002/hep.26014

Field-Weighted Citation Impact: 19.48